News

Why Is ThermoGenesis (THMO) Stock Down 37% Today?

  • ThermoGenesis¬†(NASDAQ: THMO ) stock is taking a beating on Wednesday after the company announced an update on its listing compliance. According to a ThermoGenesis filing, it has received another delisting notice from the Nasdaq Exchange.
    06/12/2024

ThermoGenesis Holdings, Inc. (THMO) Q3 2023 Earnings Call Transcript

  • ThermoGenesis Holdings, Inc. (NASDAQ:THMO ) Q3 2023 Earnings Conference Call November 13, 2023 4:30 PM ET Company Participants Paula Schwartz - Rx Communications, IR Dr. Chris Xu - Chief Executive Officer Jeff Cauble - Chief Financial Officer Conference Call Participants Sean Lee - H.C. Wainwright Operator Good day.
    11/13/2023
Profitability
Dividends
Income Statement
Balance Sheet
Cash Flow Statement
Symbol Frequently Asked Questions

ThermoGenesis Holdings, Inc. (THMO) can buy. Click on Rating Page for detail.

The price of ThermoGenesis Holdings, Inc. (THMO) is 0.3102 and it was updated on 2024-06-17 07:01:22.

Currently ThermoGenesis Holdings, Inc. (THMO) is in undervalued.

News
    
News

ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate Update

  • Conference Call to be Held Today at 1:30 p.m. PT/4:30 p.m.
    Mon, Nov. 13, 2023

ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide a Corporate Strategic Update

  • Conference Call to be Held on November 13, 2023 RANCHO CORDOVA, Calif. , Nov. 8, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced¬†that the Company will release its financial results for the third quarter ended September 30, 2023, and provide a corporate strategic update on Thursday, November 13, 2023, after the close of trading.
    Wed, Nov. 08, 2023

ThermoGenesis to Open a New 35,500 Square Foot ReadyStart-IncuStart cGMP Facility in Greater Sacramento

  • An ISO 7 cGMP Cleanroom Facility Grand Opening On October 26, 2023 RANCHO CORDOVA, Calif. , Oct. 26, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing and cell and gene therapy services, announced the grand opening of its new state-of-the-art facility, housing ISO 7 cGMP cleanroom suites, along with research and development labs.
    Thu, Oct. 26, 2023

ThermoGenesis Holdings to Present at the H.C. Wainwright 25th Annual Global Investment Conference

  • RANCHO CORDOVA, Calif. , Sept. 6, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that Chris Xu, Ph.D.
    Wed, Sep. 06, 2023

Thermogenesis Holdings, Inc. (THMO) Q2 2023 Earnings Call Transcript

  • Thermogenesis Holdings, Inc. (NASDAQ:THMO ) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Paula Schwartz - IR, Rx Communications Group Chris Xu - CEO Jeff Cauble - CFO Conference Call Participants Sean Lee - H.C. Wainwright & Co. Operator Good day, and welcome to the ThermoGenesis Holdings conference call and webcast to review financial and operating results for the second quarter ended June 30, 2023.
    Fri, Aug. 11, 2023
SEC Filings
SEC Filings